BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-25. [PMID: 7674315 DOI: 10.1093/jnci/87.15.1114] [Cited by in Crossref: 342] [Cited by in F6Publishing: 356] [Article Influence: 12.2] [Reference Citation Analysis]
Number Citing Articles
1 Ciombor KK, Eng C. Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care? J Clin Oncol 2023;:JCO2202564. [PMID: 36623236 DOI: 10.1200/JCO.22.02564] [Reference Citation Analysis]
2 Benhamou S, Fournier E, Puppa G, McKee T, Ris F, Rubbia-Brandt L, Viassolo V, Zilli T, Zlobec I, Chappuis PO, Rapiti E. Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland. BMJ Open 2022;12:e063914. [PMID: 36008070 DOI: 10.1136/bmjopen-2022-063914] [Reference Citation Analysis]
3 . Major Health Problems in Modern Society. Health Care in the United States 2022. [DOI: 10.1002/9781119812234.ch3] [Reference Citation Analysis]
4 Bian Z, Huang X, Chen Y, Meng J, Feng X, Zhang M, Zhang L, Zhou J, Liang C. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients. Int J Med Sci 2021;18:284-94. [PMID: 33390797 DOI: 10.7150/ijms.49412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Walsh MF, Cadoo K, Salo-mullen EE, Dubard-gault M, Stadler ZK, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00013-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Shaib WL, Zakka K, Staley C 3rd, Roberts A, Akce M, Wu C, Alese OB, El-Rayes BF. Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers. Oncologist 2020;25:414-21. [PMID: 31784493 DOI: 10.1634/theoncologist.2019-0558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Brédart A, De Pauw A, Colas C, Stoppa-lyonnet D, Dolbeault S. Facteurs de risque génétique. Psycho-Oncologie de L'adulte 2019. [DOI: 10.1016/b978-2-294-75811-9.00004-0] [Reference Citation Analysis]
8 Desai A, Yan Y, Gerson SL. Advances in therapeutic targeting of the DNA damage response in cancer. DNA Repair (Amst) 2018;66-67:24-9. [PMID: 29715575 DOI: 10.1016/j.dnarep.2018.04.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
9 Messerini L, Mori S, Zampi G. Pathologic Features of Hereditary Non-Polyposis Colorectal Cancer. Tumori 1996;82:114-6. [DOI: 10.1177/030089169608200204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Günel N, Yamac D, Akcali Z, Taneri F, Oguz M. The Clinicopathologic Characteristics of Colorectal Cancer in Patients under 50 years of Age: Experience of an Oncology Center. Tumori 2001;87:74-7. [DOI: 10.1177/030089160108700202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Zhang X, Ran W, Wu J, Li H, Liu H, Wang L, Xiao Y, Wang X, Li Y, Xing X. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China. PeerJ 2018;6:e4341. [PMID: 29423347 DOI: 10.7717/peerj.4341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Jimenez-garcia SN, Vazquez-cruz MA, Garcia-mier L, Contreras-medina LM, Guevara-gonzález RG, Garcia-trejo JF, Feregrino-perez AA. Phytochemical and Pharmacological Properties of Secondary Metabolites in Berries. Therapeutic Foods 2018. [DOI: 10.1016/b978-0-12-811517-6.00013-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Clarke CN, Scott Kopetz E. Molecular Markers and Mutational Analysis. Rectal Cancer 2018. [DOI: 10.1007/978-3-319-16384-0_19] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Shaib WL, Assi R, Shamseddine A, Alese OB, Staley C 3rd, Memis B, Adsay V, Bekaii-Saab T, El-Rayes BF. Appendiceal Mucinous Neoplasms: Diagnosis and Management. Oncologist. 2017;22:1107-1116. [PMID: 28663356 DOI: 10.1634/theoncologist.2017-0081] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 12.3] [Reference Citation Analysis]
15 Valle L. Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. Clin Gastroenterol Hepatol 2017;15:809-19. [PMID: 27712984 DOI: 10.1016/j.cgh.2016.09.148] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
16 Dumbovic G, Forcales SV, Perucho M. Emerging roles of macrosatellite repeats in genome organization and disease development. Epigenetics 2017;12:515-26. [PMID: 28426282 DOI: 10.1080/15592294.2017.1318235] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
17 Solomon I, Harrington E, Hooker G, Erby L, Axilbund J, Hampel H, Semotiuk K, Blanco A, Klein WMP, Giardiello F, Leonard L. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance. J Genet Couns 2017;26:866-77. [PMID: 28127677 DOI: 10.1007/s10897-017-0066-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
18 Khan SA, Morris M, Idrees K, Gimbel MI, Rosenberg S, Zeng Z, Li F, Gan G, Shia J, LaQuaglia MP, Paty PB. Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg 2016;51:1812-7. [PMID: 27558481 DOI: 10.1016/j.jpedsurg.2016.07.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
19 Karanikas M, Esebidis A. Increasing incidence of colon cancer in patients <50 years old: a new entity? Ann Transl Med 2016;4:164. [PMID: 27275477 DOI: 10.21037/atm.2016.04.13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
20 Perez RE, Shen H, Duan L, Kim RH, Kim T, Park NH, Maki CG. Modeling the Etiology of p53-mutated Cancer Cells. J Biol Chem 2016;291:10131-47. [PMID: 27022024 DOI: 10.1074/jbc.M116.724781] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tanaka M, Nakajima T, Sugano K, Yoshida T, Taniguchi H, Kanemitsu Y, Nagino M, Sekine S. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients. Histopathology 2016;69:322-8. [DOI: 10.1111/his.12941] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
22 Afrin S, Giampieri F, Gasparrini M, Forbes-Hernandez TY, Varela-López A, Quiles JL, Mezzetti B, Battino M. Chemopreventive and Therapeutic Effects of Edible Berries: A Focus on Colon Cancer Prevention and Treatment. Molecules 2016;21:169. [PMID: 26840292 DOI: 10.3390/molecules21020169] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 14.0] [Reference Citation Analysis]
23 Ahn DH, Rho JH, Tchah H, Jeon IS. Early onset of colorectal cancer in a 13-year-old girl with Lynch syndrome. Korean J Pediatr 2016;59:40-2. [PMID: 26893603 DOI: 10.3345/kjp.2016.59.1.40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Erstad DJ, Tumusiime G, Cusack JC. Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon. Ann Surg Oncol 2015;22:3433-50. [DOI: 10.1245/s10434-015-4706-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
25 Epperla N, George B. An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer. J Gastrointest Cancer 2016;47:206-9. [PMID: 26018827 DOI: 10.1007/s12029-015-9735-y] [Reference Citation Analysis]
26 Cherukuri DP, Deignan JL, Das K, Grody WW, Herschman H. Instability of a dinucleotide repeat in the 3'-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma. Mol Oncol 2015;9:1252-8. [PMID: 25817443 DOI: 10.1016/j.molonc.2015.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
27 Quetglas IM, Moeini A, Pinyol R, Llovet JM. Integration of genomic information in the clinical management of HCC. Best Pract Res Clin Gastroenterol 2014;28:831-42. [PMID: 25260311 DOI: 10.1016/j.bpg.2014.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kim ER, Kim YH. Clinical application of genetics in management of colorectal cancer. Intest Res 2014;12:184-93. [PMID: 25349592 DOI: 10.5217/ir.2014.12.3.184] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
29 Desai A, Gerson S. Exo1 independent DNA mismatch repair involves multiple compensatory nucleases. DNA Repair (Amst) 2014;21:55-64. [PMID: 25037770 DOI: 10.1016/j.dnarep.2014.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
30 Boland CR, Lynch HT. The history of Lynch syndrome. Fam Cancer. 2013;12:145-157. [PMID: 23546821 DOI: 10.1007/s10689-013-9637-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
31 Baiocchi GL, Portolani N, Vermi W, Baronchelli C, Gheza F, Zogno C, Scaglia A, Marchina E, Tiberio GA, Giulini SM. Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old. BMC Surg. 2014;14:9. [PMID: 24533633 DOI: 10.1186/1471-2482-14-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
32 Starostik P, Müller-hermelink HK. Diagnosis of microsatellite instability-positive colorectal cancer. Expert Review of Molecular Diagnostics 2014;1:71-80. [DOI: 10.1586/14737159.1.1.71] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
33 Schrader KA, Sharaf R, Alanee S, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00012-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessey E, Sheehan M, Kerin MJ. Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol. 2013;4:397-408. [PMID: 24294512 DOI: 10.3978/j.issn.2078-6891.2013.021] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
35 Wang Y, Zhou X, Song Y, Ji X, Zhang A, Zhang G, Gao Z. The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma. Gene 2013;524:28-34. [DOI: 10.1016/j.gene.2013.04.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
36 Wei C, Chen J, Pande M, Lynch PM, Frazier ML. A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome. J Cancer Res Clin Oncol 2013;139:1241-50. [PMID: 23604467 DOI: 10.1007/s00432-013-1437-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
37 Dinc B, Temel HM. A case of syncronised hereditery nonpoliposis colorectal tumor with different hystopathological type and k-ras gene mutation: case report. J Clin Med Res 2013;5:67-9. [PMID: 23390480 DOI: 10.4021/jocmr1123w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013;62:367-86. [DOI: 10.1111/his.12055] [Cited by in Crossref: 309] [Cited by in F6Publishing: 325] [Article Influence: 30.9] [Reference Citation Analysis]
39 Boland CR, Jung B, Carethers JM. Cancer of the Colon and Gastrointestinal Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00074-4] [Reference Citation Analysis]
40 Gordon OK. Cancer of the Breast and Female Reproductive Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00093-8] [Reference Citation Analysis]
41 Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol. 2013;24:1274-1282. [PMID: 23235802 DOI: 10.1093/annonc/mds614] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 12.1] [Reference Citation Analysis]
42 Rübben A, Nordhoff O. A systems approach defining constraints of the genome architecture on lineage selection and evolvability during somatic cancer evolution. Biol Open 2013;2:49-62. [PMID: 23336076 DOI: 10.1242/bio.20122543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Allera-Moreau C, Rouquette I, Lepage B, Oumouhou N, Walschaerts M, Leconte E, Schilling V, Gordien K, Brouchet L, Delisle MB, Mazieres J, Hoffmann JS, Pasero P, Cazaux C. DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients. Oncogenesis 2012;1:e30. [PMID: 23552402 DOI: 10.1038/oncsis.2012.29] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
44 Pineda M, Mur P, Iniesta MD, Borràs E, Campos O, Vargas G, Iglesias S, Fernández A, Gruber SB, Lázaro C, Brunet J, Navarro M, Blanco I, Capellá G. MLH1 methylation screening is effective in identifying epimutation carriers. Eur J Hum Genet 2012;20:1256-64. [PMID: 22763379 DOI: 10.1038/ejhg.2012.136] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
45 European Association for Study of Liver. European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599-641. [PMID: 22424278 DOI: 10.1016/j.ejca.2011.12.021] [Cited by in Crossref: 307] [Cited by in F6Publishing: 306] [Article Influence: 27.9] [Reference Citation Analysis]
46 Koh PK, Kalady M, Skacel M, Fay S, McGannon E, Shenal J, Arroyo L, Toderick K, Church J. Familial colorectal cancer type X: polyp burden and cancer risk stratification via a family history score. ANZ J Surg 2011;81:537-42. [PMID: 22295380 DOI: 10.1111/j.1445-2197.2010.05606.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
47 European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43. [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001] [Cited by in Crossref: 4014] [Cited by in F6Publishing: 4302] [Article Influence: 364.9] [Reference Citation Analysis]
48 Kumar P, Nagarajaram HA. A study on mutational dynamics of simple sequence repeats in relation to mismatch repair system in prokaryotic genomes. J Mol Evol 2012;74:127-39. [PMID: 22415400 DOI: 10.1007/s00239-012-9491-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
49 Wang VW, Koh PK, Chow WL, Lim JFY. Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore. Familial Cancer 2012;11:279-89. [DOI: 10.1007/s10689-012-9513-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
50 Gausachs M, Mur P, Corral J, Pineda M, González S, Benito L, Menéndez M, Espinàs JA, Brunet J, Iniesta MD, Gruber SB, Lázaro C, Blanco I, Capellá G. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. Eur J Hum Genet 2012;20:762-8. [PMID: 22274583 DOI: 10.1038/ejhg.2011.277] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
51 Kovac M, Laczko E, Haider R, Jiricny J, Mueller H, Heinimann K, Marra G. Familial colorectal cancer: eleven years of data from a registry program in Switzerland. Fam Cancer 2011;10:605-16. [PMID: 21671081 DOI: 10.1007/s10689-011-9458-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
52 Jäger E. Medizinische Grundlagen. Sport und körperliche Aktivität in der Onkologie 2012. [DOI: 10.1007/978-3-642-25066-8_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
53 Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand L. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn. 2011;13:271-281. [PMID: 21497289 DOI: 10.1016/j.jmoldx.2010.12.004] [Cited by in Crossref: 94] [Cited by in F6Publishing: 106] [Article Influence: 7.8] [Reference Citation Analysis]
54 Tejpar S, Saridaki Z, Delorenzi M, Bosman F, Roth AD. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle. J Natl Cancer Inst. 2011;103:841-844. [PMID: 21597023 DOI: 10.1093/jnci/djr170] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
55 Pajic M, Scarlett CJ, Chang DK, Sutherland RL, Biankin AV. Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes. Hum Genet 2011;130:93-101. [PMID: 21516344 DOI: 10.1007/s00439-011-0990-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
56 Shah NB, Lindor NM. Lower gastrointestinal tract cancer predisposition syndromes. Hematol Oncol Clin North Am 2010;24:1229-52. [PMID: 21075290 DOI: 10.1016/j.hoc.2010.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
57 da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer. 2010;9:563-570. [PMID: 20697958 DOI: 10.1007/s10689-010-9373-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
58 Lynch H. Lynch Syndrome. Encyclopedia of Cancer 2011. [DOI: 10.1007/978-3-642-16483-5_3468] [Reference Citation Analysis]
59 Widschwendter M, Gayther S, Jacobs IJ. The genetics and molecular biology of gynaecological cancer. Gynaecology 2011. [DOI: 10.1016/b978-0-7020-3120-5.00035-7] [Reference Citation Analysis]
60 Carlos RC. 38 Current Issues in Gynecology: Screening for Ovarian Cancer in the Average Risk Population and Diagnostic Evaluation of Postmenopausal Bleeding. Evidence-Based Imaging 2011. [DOI: 10.1007/978-1-4419-7777-9_38] [Reference Citation Analysis]
61 Kaliyaperumal S, Patrick SM, Williams KJ. Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition. Mutat Res 2011;706:36-45. [PMID: 21035467 DOI: 10.1016/j.mrfmmm.2010.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
62 Bouzourene H, Hutter P, Losi L, Martin P, Benhattar J. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Fam Cancer. 2010;9:167-172. [PMID: 19949877 DOI: 10.1007/s10689-009-9302-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
63 Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Jenkins M, Young J, Buchanan D, Gallinger S, Adams M, Lewis S, Willis J, Elston R, Markowitz SD, Wiesner GL. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res. 2010;70:5409-5418. [PMID: 20551049 DOI: 10.1158/0008-5472.can-10-0188] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
64 Ng K, Schrag D. Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol. 2010;28:3207-3210. [PMID: 20498398 DOI: 10.1200/jco.2010.28.9314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
65 Villanueva A, Minguez B, Forner A, Reig M, Llovet JM. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med 2010;61:317-28. [PMID: 20059340 DOI: 10.1146/annurev.med.080608.100623] [Cited by in Crossref: 170] [Cited by in F6Publishing: 186] [Article Influence: 13.1] [Reference Citation Analysis]
66 Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, Okai T. Genetics of endometrial cancers. Obstet Gynecol Int 2010;2010:984013. [PMID: 20396392 DOI: 10.1155/2010/984013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
67 Koh P, Chew M, Tan Y, Lim K, Loi C, Tang C, Eu K. Preliminary Results of Mismatch Repair Deficiency Screening via Immunohistochemical Staining in Young Asian Colorectal Cancers. Proceedings of Singapore Healthcare 2010;19:3-11. [DOI: 10.1177/201010581001900102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
68 Martinez SL, Kolodner RD. Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions. Proc Natl Acad Sci U S A 2010;107:5070-5. [PMID: 20176959 DOI: 10.1073/pnas.1000798107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
69 Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. Gynecol Oncol. 2010;116:516-521. [PMID: 20034658 DOI: 10.1016/j.ygyno.2009.11.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
70 Bosserhoff A, Hellerbrand C. Capillary Electrophoresis. Molecular Diagnostics 2010. [DOI: 10.1016/b978-0-12-374537-8.00005-5] [Reference Citation Analysis]
71 Lynch HT, Hitchins MP, Shaw TG, Lynch JF, Roy H. Historical Aspects of Lynch Syndrome. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Silva FC, Valentin MD, Ferreira Fde O, Carraro DM, Rossi BM. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J. 2009;127:46-51. [PMID: 19466295 DOI: 10.1590/s1516-31802009000100010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
73 Pillaire MJ, Selves J, Gordien K, Gourraud PA, Gentil C, Danjoux M, Do C, Negre V, Bieth A, Guimbaud R, Trouche D, Pasero P, Méchali M, Hoffmann JS, Cazaux C. A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene 2010;29:876-87. [PMID: 19901968 DOI: 10.1038/onc.2009.378] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
74 Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 2009;48:737-744. [PMID: 19455606 DOI: 10.1002/gcc.20678] [Cited by in Crossref: 146] [Cited by in F6Publishing: 155] [Article Influence: 10.4] [Reference Citation Analysis]
75 Christensen LL, Kariola R, Korhonen MK, Wikman FP, Sunde L, Gerdes AM, Okkels H, Brandt CA, Bernstein I, Hansen TV, Hagemann-Madsen R, Andersen CL, Nyström M, Ørntoft TF. Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients. Fam Cancer 2009;8:489-500. [PMID: 19697156 DOI: 10.1007/s10689-009-9274-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
76 Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009;69:7053-7061. [PMID: 19690142 DOI: 10.1158/0008-5472.can-09-0358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
77 Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol. 2009;33:691-704. [PMID: 19252434 DOI: 10.1097/pas.0b013e3181983ef7] [Cited by in Crossref: 88] [Cited by in F6Publishing: 97] [Article Influence: 6.3] [Reference Citation Analysis]
78 Strimpakos AS, Syrigos KN, Saif MW. Pharmacogenetics and biomarkers in colorectal cancer. Pharmacogenomics J 2009;9:147-60. [DOI: 10.1038/tpj.2009.8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
79 Permuth-Wey J, Boulware D, Valkov N, Livingston S, Nicosia S, Lee JH, Sutphen R, Schildkraut J, Narod S, Parker A, Coppola D, Sellers T, Pal T. Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2009;18:28-34. [PMID: 19124477 DOI: 10.1158/1055-9965.EPI-08-0713] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
80 Hussain SK, Sundquist J, Hemminki K. The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden. J Invest Dermatol 2009;129:2142-7. [PMID: 19242514 DOI: 10.1038/jid.2009.31] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
81 Yoon S, Park TS, Kim NK, Lee KA, Kim J, Song J, Kim BY, Choi JR. Three new nonsense mutations of MLH1 and MSH2 genes in Korean families with hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 2009;188:61-4. [PMID: 19100506 DOI: 10.1016/j.cancergencyto.2008.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Gupta AK, Schoen RE. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol 2009;25:59-65. [PMID: 19114775 DOI: 10.1097/MOG.0b013e32831db286] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
83 Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol 2009;472:413-37. [PMID: 19107446 DOI: 10.1007/978-1-60327-492-0_20] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 13.4] [Reference Citation Analysis]
84 Edelbrock MA, Kaliyaperumal S, Williams KJ. DNA mismatch repair efficiency and fidelity are elevated during DNA synthesis in human cells. Mutat Res 2009;662:59-66. [PMID: 19138690 DOI: 10.1016/j.mrfmmm.2008.12.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
85 Zivković V, Katić V, Gligorijević J, Andelković Z, Petrović A, Krstić M. [Lynch syndrome I: a case report]. Med Pregl 2008;61:79-82. [PMID: 18798480 DOI: 10.2298/mpns0802079z] [Reference Citation Analysis]
86 French AJ, Sargent DJ, Burgart LJ, Foster NR, Kabat BF, Goldberg R, Shepherd L, Windschitl HE, Thibodeau SN. Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. Clin Cancer Res. 2008;14:3408-3415. [PMID: 18519771 DOI: 10.1158/1078-0432.ccr-07-1489] [Cited by in Crossref: 174] [Cited by in F6Publishing: 198] [Article Influence: 11.6] [Reference Citation Analysis]
87 Bellutti M, Fry LC, Malfertheiner P, Mönkemüller K. Utility of Double Balloon Enteroscopy for Surveillance in Intestinal Polyposis Syndromes. Techniques in Gastrointestinal Endoscopy 2008;10:96-100. [DOI: 10.1016/j.tgie.2007.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
88 Chew M, Koh P, Ng K, Lim J, Ho K, Ooi B, Tang C, Eu K. PHENOTYPIC CHARACTERISTICS OF HEREDITARY NON-POLYPOSIS COLORECTAL CANCER BY THE AMSTERDAM CRITERIA: AN ASIAN PERSPECTIVE. ANZ J Surg 2008;78:556-60. [DOI: 10.1111/j.1445-2197.2008.04570.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
89 Debniak T, Lubinski J. Principles of genetic predisposition to malignancies. Hered Cancer Clin Pract 2008;6:69-72. [PMID: 19804599 DOI: 10.1186/1897-4287-6-2-69] [Reference Citation Analysis]
90 Currás E, Barreiro EW. Integration in Europe of human genetics results obtained by Spaniards in the USA: A historical perspective. Scientometrics 2008;75:473-493. [DOI: 10.1007/s11192-007-1861-2] [Reference Citation Analysis]
91 Sellers TA, Huang Y, Cunningham J, Goode EL, Sutphen R, Vierkant RA, Kelemen LE, Fredericksen ZS, Liebow M, Pankratz VS, Hartmann LC, Myer J, Iversen ES Jr, Schildkraut JM, Phelan C. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:397-404. [PMID: 18268124 DOI: 10.1158/1055-9965.EPI-07-0565] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
92 Chin L, Gray JW. Translating insights from the cancer genome into clinical practice. Nature 2008;452:553-63. [PMID: 18385729 DOI: 10.1038/nature06914] [Cited by in Crossref: 219] [Cited by in F6Publishing: 234] [Article Influence: 14.6] [Reference Citation Analysis]
93 Sabates-bellver J, Cattaneo E, Heinimann K, Jiricny J, Marra G. Getting familiar with familial colon cancer. Falk Symposium. [DOI: 10.1007/978-1-4020-6826-3_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 MOLECULAR BIOLOGY OF COLORECTAL CANCER. Surgery of the Anus, Rectum & Colon 2008. [DOI: 10.1016/b978-0-7020-2723-9.50029-4] [Reference Citation Analysis]
95 Offit K, Thom P, Bernstein D. Genetic Factors: Hereditary Cancer Predisposition Syndromes. Abeloff's Clinical Oncology 2008. [DOI: 10.1016/b978-0-443-06694-8.50015-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Brédart A, De Pauw A, Flahault C, Stoppa-lyonnet D, Dolbeault S. Facteurs de risques génétiques. Précis de psycho-oncologie de l'adulte 2008. [DOI: 10.1016/b978-2-294-07149-2.50004-9] [Reference Citation Analysis]
97 Daly MB. Genetic Screening and Counseling for High-Risk Populations. Oncology. [DOI: 10.1007/0-387-31056-8_25] [Reference Citation Analysis]
98 Lu L, Macdonald AS, Waters HR, Yu F. A Dynamic Family History model Of Hereditary Nonpolyposis Colorectal Cancer and Critical Illness Insurance. Ann actuar sci 2007;2:289-325. [DOI: 10.1017/s1748499500000373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
99 Page KM. Up a gear? The significance of an elevated mutation rate in tumorigenesis. Physics of Life Reviews 2007;4:116-27. [DOI: 10.1016/j.plrev.2007.04.001] [Reference Citation Analysis]
100 de Leon MP, Benatti P, Di Gregorio C, Losi L, Pedroni M, Ponti G, Genuardi M, Viel A, Lucci-Cordisco E, Rossi G, Roncucci L. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 2007;42:746-53. [PMID: 17505997 DOI: 10.1080/00365520601026681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
101 Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2007;5:736-42. [PMID: 17544999 DOI: 10.1016/j.cgh.2007.02.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
102 Nydam TL, McIntyre RC Jr. When cecal intubation is a "must". Gastrointest Endosc 2007;65:854-6. [PMID: 17466204 DOI: 10.1016/j.gie.2006.10.035] [Reference Citation Analysis]
103 Gupta AK, Pretlow TP, Schoen RE. Aberrant crypt foci: what we know and what we need to know. Clin Gastroenterol Hepatol 2007;5:526-33. [PMID: 17433788 DOI: 10.1016/j.cgh.2007.02.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
104 Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young M, Mcarthur G, Boussioutas A, Dobrovic A. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Familial Cancer 2007;6:301-10. [DOI: 10.1007/s10689-007-9124-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 135] [Article Influence: 7.6] [Reference Citation Analysis]
105 Wang J, Luo MH, Zhang ZX, Zhang PD, Jiang XL, Ma DW, Suo RZ, Zhao LZ, Qi QH. Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients. World J Gastroenterol 2007; 13(10): 1612-1617 [PMID: 17461458 DOI: 10.3748/wjg.v13.i10.1612] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
106 Pool-zobel B, van Loo J, Rowland I, Roberfroid MB. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br J Nutr 2002;87:S273-81. [DOI: 10.1079/bjn/2002548] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.6] [Reference Citation Analysis]
107 Boland CR, Gasché C, Marra G, Chang CL. Biology of cancer in ulcerative colitis and consequences for chemoprevention. Falk Symposium. [DOI: 10.1007/1-4020-2912-8_28] [Reference Citation Analysis]
108 Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control. 2006;17:1005-1016. [PMID: 16933051 DOI: 10.1007/s10552-006-0051-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
109 Schroering AG, Edelbrock MA, Richards TJ, Williams KJ. The cell cycle and DNA mismatch repair. Exp Cell Res 2007;313:292-304. [PMID: 17157834 DOI: 10.1016/j.yexcr.2006.10.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
110 Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol 2006; 12(37): 5932-5940 [PMID: 17009390 DOI: 10.3748/wjg.v12.i37.5932] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
111 Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:1-101. [PMID: 16690537 DOI: 10.1080/10590500600614295] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
112 Schwartz S Jr, Alazzouzi H, Perucho M. Mutational dynamics in human tumors confirm the neutral intrinsic instability of the mitochondrial D-loop poly-cytidine repeat. Genes Chromosomes Cancer. 2006;45:770-780. [PMID: 16708351 DOI: 10.1002/gcc.20340] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
113 Bonardi RDA, Sartor MC, Baldin Jr. A, Nicollelli GM, Duda JR, Olandoski M. História familial e câncer colorretal em idade precoce: deve-se indicar colectomia estendida? Rev bras colo-proctol 2006;26:244-8. [DOI: 10.1590/s0101-98802006000300003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Moore JL, Rush LM, Breneman C, Mohideen MA, Cheng KC. Zebrafish genomic instability mutants and cancer susceptibility. Genetics 2006;174:585-600. [PMID: 16888336 DOI: 10.1534/genetics.106.059386] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
115 Bilbao C, Rodríguez G, Ramírez R, Falcón O, León L, Chirino R, Rivero JF, Falcón O, Díaz-Chico BN, Díaz-Chico JC. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer. Int J Cancer. 2006;119:563-570. [PMID: 16506206 DOI: 10.1002/ijc.21862] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
116 Yearsley M, Hampel H, Lehman A, Nakagawa H, de la Chapelle A, Frankel WL. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol 2006;37:831-8. [PMID: 16784982 DOI: 10.1016/j.humpath.2006.02.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
117 Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4:323-33. [PMID: 16341812 DOI: 10.1007/s10689-005-8351-6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
118 Ricciardiello L, Boland CR. Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management. Curr Gastroenterol Rep 2005;7:412-20. [PMID: 16168241 DOI: 10.1007/s11894-005-0012-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
119 Carlos RC. Current Issues in Gynecology: Screening for Ovarian Cancer in the Average Risk Population and Diagnostic Evaluation of Postmenopausal Bleeding. Evidence-Based Imaging. [DOI: 10.1007/0-387-31216-1_30] [Reference Citation Analysis]
120 Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J Clin Oncol 2005;23:9344-50. [PMID: 16361634 DOI: 10.1200/JCO.2005.03.5915] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 4.5] [Reference Citation Analysis]
121 Gruber SB. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology 2006;130:577-87. [PMID: 16472609 DOI: 10.1053/j.gastro.2006.01.031] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
122 Raptis S, Bapat B. Genetic instability in human tumors. EXS 2006;:303-20. [PMID: 16383024 DOI: 10.1007/3-7643-7378-4_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
123 Marra G, Jiricny J. DNA Mismatch Repair and Colon Cancer. Genome Instability in Cancer Development. [DOI: 10.1007/1-4020-3764-3_4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
124 Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 2005;104:2035-47. [PMID: 16206296 DOI: 10.1002/cncr.21462] [Cited by in Crossref: 107] [Cited by in F6Publishing: 117] [Article Influence: 6.3] [Reference Citation Analysis]
125 Grady WM. Molecular basis for subdividing hereditary colon cancer? Gut 2005;54:1676-8. [PMID: 16284284 DOI: 10.1136/gut.2005.073221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
126 Lubomierski N, Plotz G, Wormek M, Engels K, Kriener S, Trojan J, Jungling B, Zeuzem S, Raedle J. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors. Cancer. 2005;104:952-961. [PMID: 16015629 DOI: 10.1002/cncr.21266] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
127 Lynch PM. Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer. Curr colorectal cancer rep 2005;1:110-116. [DOI: 10.1007/s11888-005-0007-2] [Reference Citation Analysis]
128 Jatoi I, Anderson WF. Cancer Screening. Current Problems in Surgery 2005;42:620-82. [DOI: 10.1067/j.cpsurg.2005.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
129 di Pietro M, Sabates Bellver J, Menigatti M, Bannwart F, Schnider A, Russell A, Truninger K, Jiricny J, Marra G. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology 2005;129:1047-59. [PMID: 16143142 DOI: 10.1053/j.gastro.2005.06.028] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
130 Herbst U, Fuchs JI, Teubner W, Steinberg P. Malignant transformation of human colon epithelial cells by benzo[c]phenanthrene dihydrodiolepoxides as well as 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Toxicol Appl Pharmacol 2006;212:136-45. [PMID: 16137733 DOI: 10.1016/j.taap.2005.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
131 Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espín E, Armengol M, Sijmons RH, Kleibeuker JH, Seruca R, Aaltonen LA, Imai K, Yamamoto H, Schwartz S Jr, Hofstra RM. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 2005;24:3995-8. [PMID: 15782118 DOI: 10.1038/sj.onc.1208569] [Cited by in Crossref: 116] [Cited by in F6Publishing: 125] [Article Influence: 6.4] [Reference Citation Analysis]
132 Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005;42:267-333. [PMID: 15900295 DOI: 10.1067/j.cpsurg.2005.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
133 Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-668. [PMID: 15342696 DOI: 10.1136/jmg.2004.020651] [Cited by in Crossref: 250] [Cited by in F6Publishing: 268] [Article Influence: 13.9] [Reference Citation Analysis]
134 Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005;128:1696-716. [PMID: 15887160 DOI: 10.1053/j.gastro.2005.03.036] [Cited by in Crossref: 103] [Cited by in F6Publishing: 121] [Article Influence: 5.7] [Reference Citation Analysis]
135 Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer. 2004;4:978-987. [PMID: 15573119 DOI: 10.1038/nrc1504] [Cited by in Crossref: 180] [Cited by in F6Publishing: 191] [Article Influence: 10.0] [Reference Citation Analysis]
136 Luo DC, Cai Q, Sun MH, Ni YZ, Ni SC, Chen ZJ, Li XY, Tao CW, Zhang XM, Shi DR. Clinicopathological and molecular genetic analysis of HNPCC in China. World J Gastroenterol 2005; 11(11): 1673-1679 [PMID: 15786548 DOI: 10.3748/wjg.v11.i11.1673] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
137 Edelbrock M, He H, Schroering A, Fernstrom M, Bathala S, Williams KJ. Recognition and binding of mismatch repair proteins at an oncogenic hot spot. BMC Mol Biol 2005;6:6. [PMID: 15766387 DOI: 10.1186/1471-2199-6-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
138 Inamori H, Takagi S, Tajima R, Ochiai M, Ubagai T, Sugimura T, Nagao M, Nakagama H. Frequent and multiple mutations at minisatellite loci in sporadic human colorectal and gastric cancers--possible mechanistic differences from microsatellite instability in cancer cells. Jpn J Cancer Res 2002;93:382-8. [PMID: 11985787 DOI: 10.1111/j.1349-7006.2002.tb01268.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
139 Bavoux C, Leopoldino AM, Bergoglio V, O-wang J, Ogi T, Bieth A, Judde J, Pena SDJ, Poupon M, Helleday T, Tagawa M, Machado C, Hoffmann J, Cazaux C. Up-Regulation of the Error-Prone DNA Polymerase κ Promotes Pleiotropic Genetic Alterations and Tumorigenesis. Cancer Research 2005;65:325-330. [DOI: 10.1158/0008-5472.325.65.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
140 Syngal S, Bandipalliam P, Boland CR. Surveillance of patients at high risk for colorectal cancer. Medical Clinics of North America 2005;89:61-84. [DOI: 10.1016/j.mcna.2004.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
141 Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature. 2004;432:338-341. [PMID: 15549096 DOI: 10.1038/nature03099] [Cited by in Crossref: 495] [Cited by in F6Publishing: 524] [Article Influence: 26.1] [Reference Citation Analysis]
142 Goodfellow P. Molecular Genetics of Uterine Malignancies. Cancer of the Uterus 2004. [DOI: 10.1201/b14149-2] [Reference Citation Analysis]
143 Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology 2004;127:1678-84. [PMID: 15578504 DOI: 10.1053/j.gastro.2004.10.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 105] [Article Influence: 5.1] [Reference Citation Analysis]
144 Alazzouzi H, Domingo E, González S, Blanco I, Armengol M, Espín E, Plaja A, Schwartz S, Capella G, Schwartz S Jr. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet. 2005;14:235-239. [PMID: 15563510 DOI: 10.1093/hmg/ddi021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
145 Pigatto F, Bateman A, Bunyan D, Strike P, Wilkins E, Curtis C, Duncan P, May D, Nugent K, Eccles D. Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hered Cancer Clin Pract 2004;2:175-84. [PMID: 20233461 DOI: 10.1186/1897-4287-2-4-175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
146 Watson AJ. Apoptosis and colorectal cancer. Gut 2004;53:1701-9. [PMID: 15479695 DOI: 10.1136/gut.2004.052704] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 6.1] [Reference Citation Analysis]
147 Boland CR. Clement Richard Boland, Jr., MD: A Conversation with the Editor. Baylor University Medical Center Proceedings 2004;17:444-461. [DOI: 10.1080/08998280.2004.11928011] [Reference Citation Analysis]
148 Lynch HT, Shaw TG, Lynch JF. Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 2004;129C:5-22. [PMID: 15264268 DOI: 10.1002/ajmg.c.30026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
149 Mehlen P, Fearon ER. Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol. 2004;22:3420-3428. [PMID: 15310786 DOI: 10.1200/jco.2004.02.019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 4.5] [Reference Citation Analysis]
150 Kaneko K, Kurahashi T, Makino R, Konishi K, Ito H, Katagiri A, Kumekawa Y, Hirayama Y, Yoneyama K, Kushima M, Kusano M, Tajiri H, Rembacken BJ, Mitamura K, Imawari M. Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth. Br J Cancer 2004;91:312-8. [PMID: 15213719 DOI: 10.1038/sj.bjc.6601965] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
151 Pijnenborg J, Dam-de Veen G, de Haan J, van Engeland M, Groothuis P. Defective mismatch repair and the development of recurrent endometrial carcinoma. Gynecologic Oncology 2004;94:550-9. [DOI: 10.1016/j.ygyno.2004.05.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
152 Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar S Jr, Monteiro Santos EM, Vierira Costa ML, Lopes A. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 2004;3:41-7. [PMID: 15131405 DOI: 10.1023/B:FAME.0000026810.99776.e9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
153 Half EE, Bresalier RS. Treatment of Hereditary Colorectal Cancer Syndromes. Curr Treat Options Gastroenterol 2004;7:213-24. [PMID: 15149583 DOI: 10.1007/s11938-004-0042-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Bröker LE, Rodriguez JA, Giaccone G. Molecular Pathways of Drug Resistance. Principles of Molecular Oncology 2004. [DOI: 10.1007/978-1-59259-664-5_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Half EE, Bresalier RS. Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol 2004;20:32-42. [PMID: 15703618 DOI: 10.1097/00001574-200401000-00008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
156 Carethers J. Hereditary Polyposis Syndromes. Gastrointestinal and Liver Tumors 2004. [DOI: 10.1007/978-3-642-18629-5_10] [Reference Citation Analysis]
157 Piñol V, Andreu M, Castells A, Payá A, Bessa X, Rodrigo J; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 2004;16:39-45. [PMID: 15095851 DOI: 10.1097/00042737-200401000-00007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.1] [Reference Citation Analysis]
158 Grubbs EG, Manson RJ, Ludwig KA. Hereditary Nonpolyposis Colorectal Cancer. Inherited Cancer Syndromes 2004. [DOI: 10.1007/0-387-21596-4_7] [Reference Citation Analysis]
159 Cui L, Jin HY, Cheng HY, Yan YD, Meng RG, Yu DH. Clinicopathologic characteristics of Chinese hereditary non-polyposis colorectal cancer. Chinese Journal of Digestive Diseases 2003;4:186-189. [DOI: 10.1046/j.1443-9573.2003.t01-5-.x] [Reference Citation Analysis]
160 Park S, Kim SW, Kim SH, Darwish NS, Kim WH. Lack of microsatellite instability in neoplasms of ampulla of Vater: No MSI in ampulla of Vater neoplasm. Pathology International 2003;53:667-70. [DOI: 10.1046/j.1440-1827.2003.01534.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
161 Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer. 2003;3:695-701. [PMID: 12951588 DOI: 10.1038/nrc1165] [Cited by in Crossref: 341] [Cited by in F6Publishing: 357] [Article Influence: 17.1] [Reference Citation Analysis]
162 DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc 2003;58:390-408. [PMID: 14528214 DOI: 10.1067/s0016-5107(03)00014-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
163 Baak JP, Path FR, Hermsen MA, Meijer G, Schmidt J, Janssen EA. Genomics and proteomics in cancer. Eur J Cancer 2003;39:1199-215. [PMID: 12763207 DOI: 10.1016/s0959-8049(03)00265-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 3.2] [Reference Citation Analysis]
164 Arnold CN, Goel A, Boland CR. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer. 2003;106:66-73. [PMID: 12794758 DOI: 10.1002/ijc.11176] [Cited by in Crossref: 192] [Cited by in F6Publishing: 209] [Article Influence: 9.6] [Reference Citation Analysis]
165 Fox R. Endometrial abnormalities in three sisters from a family with hereditary non-polyposis colorectal cancer syndrome. BJOG: An Internal Journal of Obs Gyn 2003;110:713-713. [DOI: 10.1046/j.1471-0528.2003.03005.x] [Reference Citation Analysis]
166 Chang DK, Goel A, Ricciardiello L, Lee DH, Chang CL, Carethers JM, Boland C. Effect of H2O2 on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Cancer Letters 2003;195:243-51. [DOI: 10.1016/s0304-3835(03)00145-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
167 Keku TO, Millikan RC, Martin C, Rahkra-Burris TK, Sandler RS. Family history of colon cancer: what does it mean and how is it useful? Am J Prev Med. 2003;24:170-176. [PMID: 12568823 DOI: 10.1016/S0749-3797(02)00590-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
168 Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003;124:1574-94. [PMID: 12761718 DOI: 10.1016/s0016-5085(03)00376-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 144] [Article Influence: 6.7] [Reference Citation Analysis]
169 Turini ME, DuBois RN. Primary prevention: phytoprevention and chemoprevention of colorectal cancer. Hematol Oncol Clin North Am 2002;16:811-40. [PMID: 12418050 DOI: 10.1016/s0889-8588(02)00030-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
170 Allen BA, Terdiman JP. Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer. Best Pract Res Clin Gastroenterol 2003;17:237-58. [PMID: 12676117 DOI: 10.1016/s1521-6918(02)00149-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
171 Sarroca C, Peltomäki P, Alfano N, Tedesco G, Della Valle A, Dominguez A, Lynch HT. Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Cancer Genetics and Cytogenetics 2003;142:13-20. [DOI: 10.1016/s0165-4608(02)00766-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
172 Cai SJ, Xu Y, Cai GX, Lian P, Guan ZQ, Mo SJ, Sun MH, Cai Q, Shi DR. Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003; 9(2): 284-287 [PMID: 12532449 DOI: 10.3748/wjg.v9.i2.284] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
173 Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol 2003; 9(1): 26-29 [PMID: 12508345 DOI: 10.3748/wjg.v9.i1.26] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
174 Piver MS, Frank TS. Epidemiology of Ovarian Cancer. Diagnosis and Management of Ovarian Disorders 2003. [DOI: 10.1016/b978-012053642-9/50022-3] [Reference Citation Analysis]
175 Song YM, Zheng S. Analysis for phenotype of HNPCC in China. World J Gastroenterol 2002; 8(5): 837-840 [PMID: 12378626 DOI: 10.3748/wjg.v8.i5.837] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
176 Trowbridge B, Burt RW. Colorectal cancer screening. Surgical Clinics of North America 2002;82:943-57. [DOI: 10.1016/s0039-6109(02)00045-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
177 Kabbani W, Houlihan PS, Luthra R, Hamilton SR, Rashid A. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol. 2002;15:599-605. [PMID: 12065772 DOI: 10.1038/modpathol.3880572] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 4.0] [Reference Citation Analysis]
178 Neibergs HL, Hein DW, Spratt JS. Genetic profiling of colon cancer. J Surg Oncol. 2002;80:204-213. [PMID: 12210035 DOI: 10.1002/jso.10131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
179 Rossi BM, Lopes A, Oliveira Ferreira F, Nakagawa WT, Napoli Ferreira CC, Casali Da Rocha JC, Simpson CC, Simpson AJ. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555-61. [PMID: 12095971 DOI: 10.1007/BF02573891] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
180 Lynch HT, Lynch JF. Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies. Biochimie 2002;84:3-17. [PMID: 11900873 DOI: 10.1016/s0300-9084(01)01363-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
181 Peterson KA, Disario JA. Secondary prevention: screening and surveillance of persons at average and high risk for colorectal cancer. Hematology/Oncology Clinics of North America 2002;16:841-65. [DOI: 10.1016/s0889-8588(02)00031-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
182 Alvino E, Marra G, Pagani E, Falcinelli S, Pepponi R, Perrera C, Haider R, Castiglia D, Ferranti G, Bonmassar E, Jiricny J, Zambruno G, D'Atri S. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma. J Invest Dermatol 2002;118:79-86. [PMID: 11851879 DOI: 10.1046/j.0022-202x.2001.01611.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
183 Cao Y, Pieretti M, Marshall J, Khattar NH, Chen B, Kam-Morgan L, Lynch H. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol 2002;97:1822-7. [PMID: 12135043 DOI: 10.1111/j.1572-0241.2002.05850.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
184 Middelton L, Dimond E, Calzone K, Davis J, Jenkins J. The Role of the Nurse in Cancer Genetics: . Cancer Nursing 2002;25:196-206. [DOI: 10.1097/00002820-200206000-00005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
185 Gown A. Genogenic immunohistochemistry: a new era in diagnostic immunohistochemistry. Current Diagnostic Pathology 2002;8:193-200. [DOI: 10.1054/cdip.2002.0116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
186 Funato T, Uehara S, Takahashi M, Kozawa K, Satoh J, Sasaki T, Kaku M. Microsatellite instability in gonadal tumors of XY pure gonadal dysgenesis patients. Int J Gynecol Cancer 2002;12:192-7. [PMID: 11975679 DOI: 10.1046/j.1525-1438.2002.01094.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Hussein MR, Wood GS. Microsatellite instability in human melanocytic skin tumors: an incidental finding or a pathogenetic mechanism? J Cutan Pathol 2002;29:1-4. [PMID: 11841510 DOI: 10.1034/j.1600-0560.2002.290101.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
188 Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer. 2002;98:774-779. [PMID: 11920650 DOI: 10.1002/ijc.10240] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
189 Zhao B, Wang ZJ, Xu YF, Wan YL, Li P, Huang YT. Report of 16 kindreds and one kindred with hMLH1 germline mutation. World J Gastroenterol 2002; 8(2): 263-266 [PMID: 11925604 DOI: 10.3748/wjg.v8.i2.263] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
190 Cravo M, Afonso AJ, Lage P, Albuquerque C, Maia L, Lacerda C, Fidalgo P, Chaves P, Cruz C, Nobre-Leitão C. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing. Gut 2002;50:405-12. [PMID: 11839723 DOI: 10.1136/gut.50.3.405] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
191 Rovella V, Carrara S, Crucitti SC, Coco C, Magistrelli P, Lucci-Cordisco E, Anti M, Neri G, Genuardi M. Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population. Ann Oncol 2001;12:813-8. [PMID: 11484957 DOI: 10.1023/a:1011182025556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
192 Ponz D. Prevention and chemoprevention of colorectal neoplasms. Dig Liver Dis 2002;34:59-69. [PMID: 11926575 DOI: 10.1016/s1590-8658(02)80061-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
193 Ponz de Leon M. Prevention and Chemoprevention of Colorectal Neoplasms. Colorectal Cancer 2002. [DOI: 10.1007/978-3-642-56008-8_6] [Reference Citation Analysis]
194 Ponz de Leon M. Hereditary Non-polyposis Colorectal Cancer (Lynch Syndrome). Colorectal Cancer 2002. [DOI: 10.1007/978-3-642-56008-8_10] [Reference Citation Analysis]
195 Furlan D, Casati B, Cerutti R, Facco C, Terracciano L, Capella C, Maria Chiaravalli A. Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instability. J Pathol 2002;197:603-9. [DOI: 10.1002/path.1162] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
196 Boman BM, Melchert L, Fields JZ. Hereditary Cancer. The Molecular Basis of Human Cancer 2002. [DOI: 10.1007/978-1-59259-125-1_8] [Reference Citation Analysis]
197 Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery 2002;131:S63-70. [DOI: 10.1067/msy.2002.119306] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
198 Ponz de Leon M. Colorectal Cancer Screening and Surveillance. Colorectal Cancer 2002. [DOI: 10.1007/978-3-642-56008-8_5] [Reference Citation Analysis]
199 Frosina G. Overexpression of enzymes that repair endogenous damage to DNA: Overexpression of DNA repair enzymes. European Journal of Biochemistry 2000;267:2135-49. [DOI: 10.1046/j.1432-1327.2000.01266.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 3.7] [Reference Citation Analysis]
200 Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, Loda M, Appelman HD, Cho KR, Fearon ER. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol. 2001;159:2239-2248. [PMID: 11733373 DOI: 10.1016/s0002-9440(10)63074-x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 173] [Article Influence: 7.3] [Reference Citation Analysis]
201 Cai Q, Sun MH, Lu HF, Zhang TM, Mo SJ, Xu Y, Cai SJ, Zhu XZ, Shi DR. Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families. World J Gastroenterol 2001; 7(6): 805-810 [PMID: 11854906 DOI: 10.3748/wjg.v7.i6.805] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
202 Goel A, Arnold CN, Boland CR. Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights. Gastroenterology 2001;121:1497-502. [PMID: 11729129 DOI: 10.1053/gast.2001.29978] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
203 Edmondson RJ, Monaghan JM. The epidemiology of ovarian cancer. Int J Gynecol Cancer 2001;11:423-9. [DOI: 10.1046/j.1525-1438.2001.01053.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 3.0] [Reference Citation Analysis]
204 Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001;1:109-17. [DOI: 10.1038/35101065] [Cited by in Crossref: 290] [Cited by in F6Publishing: 333] [Article Influence: 13.2] [Reference Citation Analysis]
205 Freyer G, Ligneau B, Schlumberger M, Blandy C, Contedevolx B, Trillet-lenoir V, Lenoir G, Chau N, Dazord A. Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations. Annals of Oncology 2001;12:1461-5. [DOI: 10.1023/a:1012593410510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
206 Huang SC, Lavine JE, Boland PS, Newbury RO, Kolodner R, Pham TT, Arnold CN, Boland CR, Carethers JM. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001;138:629-35. [PMID: 11343035 DOI: 10.1067/mpd.2001.113620] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
207 Sharma A, James M, Donaldson A, Fox R. Hereditary non-polyposis colorectal cancer syndrome: combined risk of gastrointestinal and gynaecological cancer. British Journal of Obstetrics and Gynaecology 2001;108:671-7. [DOI: 10.1016/s0306-5456(00)00174-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
208 Sharma A, James M, Donaldson A, Fox R. Hereditary non-polyposis colorectal cancer syndrome: combined risk of gastrointestinal and gynaecological cancer. BJOG: An Internal Journal of Obs Gyn 2001;108:671-677. [DOI: 10.1111/j.1471-0528.2001.00174.x] [Reference Citation Analysis]
209 Robson ME, Boyd J, Borgen PI, Cody HS. Hereditary breast cancer. Current Problems in Surgery 2001;38:387-480. [DOI: 10.1016/s0011-3840(01)70035-4] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 5.1] [Reference Citation Analysis]
210 Richetta A, Ottini L, Falchetti M, Innocenzi D, Bottoni U, Faiola R, Mariani-costantini R, Calvieri S. Instability at sequence repeats in melanocytic tumours: . Melanoma Research 2001;11:283-9. [DOI: 10.1097/00008390-200106000-00010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
211 Furihata M, Takeuchi T, Ohtsuki Y, Terao N, Kuwahara M, Shuin T. GENETIC ANALYSIS OF hMLH1 IN TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: PROMOTER METHYLATION OR MUTATION. Journal of Urology 2001;165:1760-4. [DOI: 10.1016/s0022-5347(05)66409-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
212 Furihata M, Takeuchi T, Ohtsuki Y, Terao N, Kuwahara M, Shuin T. GENETIC ANALYSIS OF hMLH1 IN TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: PROMOTER METHYLATION OR MUTATION. The Journal of Urology 2001. [DOI: 10.1097/00005392-200105000-00096] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
213 Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535. [PMID: 11159189 DOI: 10.1016/s0002-9440(10)63994-6] [Cited by in Crossref: 363] [Cited by in F6Publishing: 394] [Article Influence: 16.5] [Reference Citation Analysis]
214 Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000;2:20-28. [PMID: 11272898 DOI: 10.1016/s1525-1578(10)60611-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 115] [Article Influence: 5.0] [Reference Citation Analysis]
215 Brunicardi FC. Molecular surgery and biology. Am J Surg 2000;180:397-401. [PMID: 11182386 DOI: 10.1016/s0002-9610(00)00494-3] [Reference Citation Analysis]
216 Hutter P, Couturier A, Rey-Berthod C. Two common forms of the human MLH1 gene may be associated with functional differences. J Med Genet 2000;37:776-81. [PMID: 11015456 DOI: 10.1136/jmg.37.10.776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
217 Kuraguchi M, Edelmann W, Yang K, Lipkin M, Kucherlapati R, Brown AM. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency. Oncogene. 2000;19:5755-5763. [PMID: 11126362 DOI: 10.1038/sj.onc.1203962] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
218 Gazdar A, Maitra A. Adenocarcinomas. Encyclopedia of Genetics 2001. [DOI: 10.1006/rwgn.2001.1540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
219 Kinney AY, Devellis BM, Skrzynia C, Millikan R. Genetic testing for colorectal carcinoma susceptibility: Focus group responses of individuals with colorectal carcinoma and first-degree relatives. Cancer 2001;91:57-65. [DOI: 10.1002/1097-0142(20010101)91:1<57::aid-cncr8>3.0.co;2-u] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
220 Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB. Hereditary non-polyposis colorectal cancer: an updated review. Eur J Surg Oncol. 2000;26:635-645. [PMID: 11078609 DOI: 10.1053/ejso.2000.0974] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
221 Schwartz S Jr, Perucho M. Somatic mutations in mitochondrial DNA do not associate with nuclear microsatellite instability in gastrointestinal cancer. Gastroenterology 2000;119:1806-8. [PMID: 11187438 DOI: 10.1016/s0016-5085(00)70042-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
222 Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000;37:641-645. [PMID: 10978352 DOI: 10.1136/jmg.37.9.641] [Cited by in Crossref: 184] [Cited by in F6Publishing: 203] [Article Influence: 8.0] [Reference Citation Analysis]
223 Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA. 2000;97:10872-10877. [PMID: 10984511 DOI: 10.1073/pnas.190210897] [Cited by in Crossref: 173] [Cited by in F6Publishing: 175] [Article Influence: 7.5] [Reference Citation Analysis]
224 Voskuil DW, Kampman E, van Geloof W, Grubben M, Kok F, van Muijen G, Nagengast F, Vasen H, van't Veer P. No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas. Dig Dis Sci 2000;45:2187-94. [PMID: 11215737 DOI: 10.1023/a:1026485117125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
225 . Genetics testing for colon cancer: Joint statement of the American College of Medical Genetics and American Society of Human Genetics: Joint Test and Technology Transfer Committee Working Group. Genet Med 2000;2:362-6. [DOI: 10.1097/00125817-200011000-00012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
226 Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Qian C, Christensen E, Roche PC, Smith DI, Thibodeau SN. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling. Nat Genet 2000;26:146-7. [DOI: 10.1038/79859] [Cited by in Crossref: 370] [Cited by in F6Publishing: 394] [Article Influence: 16.1] [Reference Citation Analysis]
227 Rodriguez-bigas MA, Stoler DL, Bertario L, Anderson GR, Baba S. Colorectal Cancer. Surgical Oncology Clinics of North America 2000;9:643-52. [DOI: 10.1016/s1055-3207(18)30098-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Abe Y, Masuda H. Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers. J Surg Oncol 2000;74:249-56. [PMID: 10962455 DOI: 10.1002/1096-9098(200008)74:4<249::aid-jso2>3.0.co;2-s] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
229 Coughlin SS, Burke W. Public health assessment of genetic predisposition to cancer. Genetics and Public Health in the 21st Century 2000. [DOI: 10.1093/acprof:oso/9780195128307.003.0009] [Reference Citation Analysis]
230 Schoen RE. Families at risk for colorectal cancer: risk assessment and genetic testing. J Clin Gastroenterol 2000;31:114-20. [PMID: 10993425 DOI: 10.1097/00004836-200009000-00005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
231 Burt RW. Colon cancer screening. Gastroenterology 2000;119:837-53. [PMID: 10982778 DOI: 10.1053/gast.2000.16508] [Cited by in Crossref: 246] [Cited by in F6Publishing: 254] [Article Influence: 10.7] [Reference Citation Analysis]
232 Boland CR. Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci. 2000;910:50-59; discussion 59-61. [PMID: 10911905 DOI: 10.1111/j.1749-6632.2000.tb06700.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
233 de Leon MP, Benatti P, Pedroni M, Viel A, Genuardi M, Percesepe A, Roncucci L. Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum. Am J Gastroenterol 2000;95:2110-5. [PMID: 10950068 DOI: 10.1111/j.1572-0241.2000.02163.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
234 Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000;119:323-32. [PMID: 10930367 DOI: 10.1053/gast.2000.9361] [Cited by in Crossref: 171] [Cited by in F6Publishing: 179] [Article Influence: 7.4] [Reference Citation Analysis]
235 Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem. 2000;275:18424-18431. [PMID: 10747992 DOI: 10.1074/jbc.M001140200] [Cited by in Crossref: 142] [Cited by in F6Publishing: 152] [Article Influence: 6.2] [Reference Citation Analysis]
236 Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-92. [PMID: 10856109 DOI: 10.1200/JCO.2000.18.12.2484] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 3.5] [Reference Citation Analysis]
237 Syngal S, Clarke G, Bandipalliam P. Potential roles of genetic biomarkers in colorectal cancer chemoprevention. J Cell Biochem Suppl 2000;34:28-34. [PMID: 10762012 DOI: 10.1002/(sici)1097-4644(2000)77:34+<28::aid-jcb7>3.0.co;2-r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
238 Yin J, Kong D, Wang S, Zou TT, Souza RF, Smolinski KN, Lynch PM, Hamilton SR, Sugimura H, Powell SM, Young J, Abraham JM, Meltzer SJ. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat 1997;10:474-8. [PMID: 9401011 DOI: 10.1002/(SICI)1098-1004(1997)10:6<474::AID-HUMU9>3.0.CO;2-D] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
239 Tunca B, Egeli U, Zorluoğlu A, Yilmazlar T, Yerci O, Kizil A. The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives. Cancer Lett 2000;152:201-9. [PMID: 10773413 DOI: 10.1016/s0304-3835(00)00334-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
240 Ma AH, Xia L, Littman SJ, Swinler S, Lader G, Polinkovsky A, Olechnowicz J, Kasturi L, Lutterbaugh J, Modrich P, Veigl ML, Markowitz SD, Sedwick WD. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability. Oncogene 2000;19:2249-56. [PMID: 10822375 DOI: 10.1038/sj.onc.1203568] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
241 Matton N, Simonetti J, Williams K. Identification of Mismatch Repair Protein Complexes in HeLa Nuclear Extracts and Their Interaction with Heteroduplex DNA. Journal of Biological Chemistry 2000;275:17808-13. [DOI: 10.1074/jbc.m909794199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
242 Tunca B, Egeli Ü, Zorluoglu A, Yılmazlar T, Yerci Ö, Kızıl A. The Expression Frequency of Common Fragile Sites and Genetic Predisposition to Colon Cancer. Cancer Genetics and Cytogenetics 2000;119:139-45. [DOI: 10.1016/s0165-4608(99)00228-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
243 Markowitz S. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000;1470:M13-20. [PMID: 10656986 DOI: 10.1016/s0304-419x(99)00031-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.2] [Reference Citation Analysis]
244 Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1-18. [PMID: 10741640 DOI: 10.1046/j.1365-2184.2000.00159.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 3.2] [Reference Citation Analysis]
245 Chen WD, Eshleman JR, Aminoshariae MR, Ma AH, Veloso N, Markowitz SD, Sedwick WD, Veigl ML. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells. J Natl Cancer Inst 2000;92:480-5. [PMID: 10716966 DOI: 10.1093/jnci/92.6.480] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
246 Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000;36:49-54. [PMID: 10741294 DOI: 10.1016/s0959-8049(99)00208-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 2.9] [Reference Citation Analysis]
247 Burt RW. Familial association. Adv Exp Med Biol 1999;470:99-104. [PMID: 10709679 DOI: 10.1007/978-1-4615-4149-3_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
248 Parc YR, Halling KC, Burgart LJ, Mcdonnell SK, Schaid DJ, Thibodeau SN, Halling AC. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology. Int J Cancer 2000;86:60-6. [DOI: 10.1002/(sici)1097-0215(20000401)86:1<60::aid-ijc9>3.0.co;2-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 2.5] [Reference Citation Analysis]
249 Percesepe A, Pedroni M, Sala E, Menigatti M, Borghi F, Losi L, Viel A, Genuardi M, Benatti P, Roncucci L, Peltom�ki P, Ponz de Leon M. Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts. Genes Chromosom Cancer 2000;27:424-9. [DOI: 10.1002/(sici)1098-2264(200004)27:4<424::aid-gcc13>3.0.co;2-m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
250 Siah SP, Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G, Rudzki Z. Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 2000;60:135-42. [DOI: 10.1023/a:1006315315060] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
251 Sia EA, Butler CA, Dominska M, Greenwell P, Fox TD, Petes TD. Analysis of microsatellite mutations in the mitochondrial DNA of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 2000;97:250-5. [PMID: 10618404 DOI: 10.1073/pnas.97.1.250] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 2.5] [Reference Citation Analysis]
252 Bonnal C, Ravery V, Toublanc M, Bertrand G, Boccon-gibod L, Hénin D, Grandchamp B. Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology 2000;55:287-91. [DOI: 10.1016/s0090-4295(99)00399-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
253 Jakubowska A, G�rski B, Kurzawski G, Debniak T, Hadaczek P, Cybulski C, Kladny J, Oszurek O, Scott RJ, Lubinski J. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes. Hum Mutat 2001;17:52-60. [DOI: 10.1002/1098-1004(2001)17:1<52::aid-humu6>3.0.co;2-e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
254 Egeli �, �zkan L, Tunca B, Kahraman S, �e�ener G, Erg�l E, Engin K. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites. Head Neck 2000;22:591-8. [DOI: 10.1002/1097-0347(200009)22:6<591::aid-hed8>3.0.co;2-c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
255 Moustacchi E. DNA damage and repair: consequences on dose-responses. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2000;464:35-40. [DOI: 10.1016/s1383-5718(99)00164-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
256 Platz EA, Giovannuccpa E. Colon and Rectal Cancer in Women. Women and Health 2000. [DOI: 10.1016/b978-012288145-9/50087-5] [Reference Citation Analysis]
257 Karnes WE. Implications of low COX-2 expression in colorectal neoplasms with defective DNA mismatch repair. J Cell Biochem 2000;77:23-7. [DOI: 10.1002/(sici)1097-4644(2000)77:34+<23::aid-jcb6>3.0.co;2-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
258 Cook LS, Weiss NS. Endometrial Cancer. Women and Health 2000. [DOI: 10.1016/b978-012288145-9/50083-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
259 Ho JW, Yuen S, Chung L, Kwan KY, Chan T, Leung S, Chan AS, Tse C, Lam PW, Luk IS. Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients. Int J Cancer 2000;89:356-60. [DOI: 10.1002/1097-0215(20000720)89:4<356::aid-ijc7>3.0.co;2-j] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
260 Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-petsotas M, Bassi DE, Ruggeri BA, Klein-szanto AJ, Testa JR, Neri G, Bellacosa A. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 1999;23:266-8. [DOI: 10.1038/15443] [Cited by in Crossref: 146] [Cited by in F6Publishing: 154] [Article Influence: 6.1] [Reference Citation Analysis]
261 Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999;23:1248-55. [PMID: 10524526 DOI: 10.1097/00000478-199910000-00010] [Cited by in Crossref: 170] [Cited by in F6Publishing: 164] [Article Influence: 7.1] [Reference Citation Analysis]
262 Hickman MJ, Samson LD. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci USA. 1999;96:10764-10769. [PMID: 10485900 DOI: 10.1073/pnas.96.19.10764] [Cited by in Crossref: 210] [Cited by in F6Publishing: 219] [Article Influence: 8.8] [Reference Citation Analysis]
263 Papadopoulos N. Microsatellite instability (MSI) in non-colonic, non-HNPCC tumors: 'instable' evidence? Ann Oncol 1999;10:751-2. [PMID: 10470419 DOI: 10.1023/a:1008389100079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
264 Sedwick W, Markowitz SD, Veigl ML. Mismatch repair and drug responses in cancer. Drug Resistance Updates 1999;2:295-306. [DOI: 10.1054/drup.1999.0099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
265 Augenlicht LH, Bordonaro M, Heerdt BG, Mariadason J, Velcich A. Cellular Mechanisms of Risk and Transformation. Annals NY Acad Sci 1999;889:20-31. [DOI: 10.1111/j.1749-6632.1999.tb08720.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
266 Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D. Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin Genet 1999;55:318-24. [PMID: 10422801 DOI: 10.1034/j.1399-0004.1999.550504.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.1] [Reference Citation Analysis]
267 Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 1999;117:350-8. [PMID: 10419916 DOI: 10.1053/gast.1999.0029900350] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 3.9] [Reference Citation Analysis]
268 Lanza G, Gafà R, Matteuzzi M, Santini A. Medullary-Type Poorly Differentiated Adenocarcinoma of the Large Bowel: A Distinct Clinicopathologic Entity Characterized by Microsatellite Instability and Improved Survival. JCO 1999;17:2429-2429. [DOI: 10.1200/jco.1999.17.8.2429] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 2.8] [Reference Citation Analysis]
269 Coughlin SS, Miller DS. Public health perspectives on testing for colorectal cancer susceptibility genes. Am J Prev Med. 1999;16:99-104. [PMID: 10343885 DOI: 10.1016/s0749-3797(98)00137-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
270 Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, Howell SB, Boland CR. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 1999;117:123-31. [PMID: 10381918 DOI: 10.1016/s0016-5085(99)70558-5] [Cited by in Crossref: 322] [Cited by in F6Publishing: 336] [Article Influence: 13.4] [Reference Citation Analysis]
271 de Leon MP, Pedroni M, Benatti P, Percesepe A, Di Gregorio C, Foroni M, Rossi G, Genuardi M, Neri G, Leonardi F, Viel A, Capozzi E, Boiocchi M, Roncucci L. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 1999;45:32-8. [PMID: 10369701 DOI: 10.1136/gut.45.1.32] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
272 Boyd J, Rhei E, Federici MG, Borgen PI, Watson P, Franklin B, Karr B, Lynch J, Lemon SJ, Lynch HT. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999;53:87-91. [PMID: 10206076 DOI: 10.1023/a:1006030116357] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
273 Rashid A, Zahurak M, Goodman SN, Hamilton SR. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 1999;44:826-33. [PMID: 10323885 DOI: 10.1136/gut.44.6.826] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 2.4] [Reference Citation Analysis]
274 Box JC, Rodriguez-Bigas MA, Weber TK, Petrelli NJ. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 1999;42:717-21. [PMID: 10378594 DOI: 10.1007/BF02236924] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
275 Gotoh K, Yatabe Y, Sugiura T, Takagi K, Ogawa M, Takahashi T, Mitsudomi T. Frameshift mutations in TGFbetaRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers. Carcinogenesis 1999;20:499-502. [PMID: 10190568 DOI: 10.1093/carcin/20.3.499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
276 Pedroni M, Tamassia MG, Percesepe A, Roncucci L, Benatti P, Lanza G Jr, Gafà R, Di Gregorio C, Fante R, Losi L, Gallinari L, Scorcioni F, Vaccina F, Rossi G, Cesinaro AM, Ponz de Leon M. Microsatellite instability in multiple colorectal tumors. Int J Cancer 1999;81:1-5. [PMID: 10077143 DOI: 10.1002/(sici)1097-0215(19990331)81:1<1::aid-ijc1>3.0.co;2-k] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 2.6] [Reference Citation Analysis]
277 Leung SY, Yuen ST, Chung LP, Chu KM, Wong MP, Branicki FJ, Ho JC. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese. Br J Cancer 1999;79:582-8. [PMID: 10027334 DOI: 10.1038/sj.bjc.6690092] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
278 Liu VF, Bhaumik D, Wang TS. Mutator phenotype induced by aberrant replication. Mol Cell Biol 1999;19:1126-35. [PMID: 9891047 DOI: 10.1128/MCB.19.2.1126] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
279 Glaser E, Grogan L. Molecular genetics of gastrointestinal malignancies. Seminars in Oncology Nursing 1999;15:3-9. [DOI: 10.1016/s0749-2081(99)80034-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
280 Kato T, Yatagai F, Glickman BW, Tachibana A, Ikenaga M. Specificity of mutations in the PMS2-deficient human tumor cell line HEC-1-A. Mutat Res 1998;422:279-83. [PMID: 9838164 DOI: 10.1016/s0027-5107(98)00208-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
281 Freyer G, Dazord A, Schlumberger M, Conte-devolx B, Ligneau B, Trillet-lenoir V, Lenoir G. Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation. Annals of Oncology 1999;10:87-96. [DOI: 10.1023/a:1008349318728] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
282 Burke W. Genetics of Breast and Ovarian Cancer. Cancer Genetics for the Clinician 1999. [DOI: 10.1007/978-1-4615-4699-3_4] [Reference Citation Analysis]
283 Bekradda M, Cvitkovic E. New possibilities in chemotherapy for colorectal cancer. Annals of Oncology 1999;10:S105-S112. [DOI: 10.1093/annonc/10.suppl_6.s105] [Reference Citation Analysis]
284 Glaser EM. Inherited predisposition to colon cancer: . Cancer Nursing 1998;21:377-83. [DOI: 10.1097/00002820-199812000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
285 Stark A. Transient appearance of the mutator phenotype during carcinogenesis as a possible explanation for the lack of mini/microsatellite instability in many late stage tumors. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1998;421:221-5. [DOI: 10.1016/s0027-5107(98)00209-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
286 Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol. 1998;153:1063-1078. [PMID: 9777938 DOI: 10.1016/s0002-9440(10)65651-9] [Cited by in Crossref: 130] [Cited by in F6Publishing: 144] [Article Influence: 5.2] [Reference Citation Analysis]
287 Giaretti W, Rapallo A, Geido E, Sciutto A, Merlo F, Risio M, Rossini FP. Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation. Am J Pathol 1998;153:1201-9. [PMID: 9777951 DOI: 10.1016/S0002-9440(10)65664-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
288 Boyer JC, Risinger JI, Farber RA. Stability of Microsatellites in Myeloid Neoplasias. Cancer Genetics and Cytogenetics 1998;106:54-61. [DOI: 10.1016/s0165-4608(98)00043-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
289 Boland CR, Sato J, Saito K, Carethers JM, Marra G, Laghi L, Chauhan. Genetic Instability and Chromosomal Aberrations in Colorectal Cancer: A Review of the Current Models. Cancer Detect Prev 1998;22:377-82. [DOI: 10.1046/j.1525-1500.1998.00050.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
290 Kim WH, Lee HW, Park SH, Kim YI, Chi JG. Microsatellite instability in young patients with colorectal cancer. Pathology International 1998;48:586-94. [DOI: 10.1111/j.1440-1827.1998.tb03955.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
291 Wells RD, Bacolla A, Bowater RP. Instabilities of triplet repeats: factors and mechanisms. Results Probl Cell Differ 1998;21:133-65. [PMID: 9670316 DOI: 10.1007/978-3-540-69680-3_4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
292 Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A 1998;95:8698-702. [PMID: 9671741 DOI: 10.1073/pnas.95.15.8698] [Cited by in Crossref: 450] [Cited by in F6Publishing: 489] [Article Influence: 18.0] [Reference Citation Analysis]
293 Rodriguez-Bigas MA, Vasen HF, Lynch HT, Watson P, Myrhøj T, Järvinen HJ, Mecklin JP, Macrae F, St John DJ, Bertario L, Fidalgo P, Madlensky L, Rozen P. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 1998;83:240-4. [PMID: 9669805 DOI: 10.1002/(sici)1097-0142(19980715)83:2<240::aid-cncr6>3.0.co;2-u] [Cited by in Crossref: 89] [Cited by in F6Publishing: 104] [Article Influence: 3.6] [Reference Citation Analysis]
294 Weiner H. Notes on an evolutionary medicine. Psychosom Med 1998;60:510-20. [PMID: 9710299 DOI: 10.1097/00006842-199807000-00020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
295 Burgess AW. Growth control mechanisms in normal and transformed intestinal cells. Philos Trans R Soc Lond B Biol Sci 1998;353:903-9. [PMID: 9684287 DOI: 10.1098/rstb.1998.0254] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
296 Sugimura T. Cancer prevention: past, present, future. Mutat Res 1998;402:7-14. [PMID: 9675231 DOI: 10.1016/s0027-5107(97)00276-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
297 Polaczek P, Putzke AP, Leong K, Bitter GA. Functional genetic tests of DNA mismatch repair protein activity in Saccharomyces cerevisiae. Gene 1998;213:159-67. [PMID: 9630599 DOI: 10.1016/s0378-1119(98)00150-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
298 MacPhee DG. Epigenetics and epimutagens: some new perspectives on cancer, germ line effects and endocrine disrupters. Mutat Res 1998;400:369-79. [PMID: 9685697 DOI: 10.1016/s0027-5107(98)00046-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
299 Jackson AL, Newcomb TG, Loeb LA. Origin of multiple mutations in human cancers. Drug Metab Rev 1998;30:285-304. [PMID: 9606605 DOI: 10.3109/03602539808996313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
300 Iaccarino I, Marra G, Palombo F, Jiricny J. hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha. EMBO J 1998;17:2677-86. [PMID: 9564049 DOI: 10.1093/emboj/17.9.2677] [Cited by in Crossref: 127] [Cited by in F6Publishing: 138] [Article Influence: 5.1] [Reference Citation Analysis]
301 Lin KM, Shashidharan M, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lanspa SJ, Lemon SJ, Watson P, Lynch HT. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998;41:428-33. [PMID: 9559626 DOI: 10.1007/BF02235755] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 2.9] [Reference Citation Analysis]
302 Kanomata N, Eble JN, Halling KC. Microsatellite instability is uncommon in young patients with renal cell carcinoma. Cancer Genet Cytogenet 1998;101:123-7. [PMID: 9494613 DOI: 10.1016/s0165-4608(97)00229-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
303 Glaab WE, Risinger JI, Umar A, Barrett JC, Kunkel TA, Tindall KR. Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate. Mutat Res 1998;398:197-207. [PMID: 9626980 DOI: 10.1016/s0027-5107(98)00004-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
304 Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998;2:67-71. [PMID: 9841970 DOI: 10.1016/s1091-255x(98)80105-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 99] [Article Influence: 3.7] [Reference Citation Analysis]
305 Dimond E, Calzone K, Davis J, Jenkins J. The role of the nurse in cancer genetics. Cancer Nurs 1998;21:57-70; quiz 71-5. [PMID: 9494232 DOI: 10.1097/00002820-199802000-00008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
306 Augenlicht LH. The molecular genetics of colonic cancer. Cancer Treatment and Research 1998. [DOI: 10.1007/978-1-4615-4977-2_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
307 Gold LI, Parekh T. Role for Transforming Growth Factor-β. Pancreatic Cancer 1998. [DOI: 10.1007/978-1-4612-1810-4_5] [Reference Citation Analysis]
308 Grem JL. Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approaches. Cancer Treat Res 1998;98:293-338. [PMID: 10326673 DOI: 10.1007/978-1-4615-4977-2_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
309 Schär P, Jiricny J. Eukaryotic Mismatch Repair. DNA Repair 1998. [DOI: 10.1007/978-3-642-48770-5_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
310 Lynch HT, Fusaro RM, Lynch JF. Cancer genetics in the new era of molecular biology. Ann N Y Acad Sci 1997;833:1-28. [PMID: 9616736 DOI: 10.1111/j.1749-6632.1997.tb48588.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
311 Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62. [PMID: 9392616 DOI: 10.1093/jnci/89.23.1758] [Cited by in Crossref: 772] [Cited by in F6Publishing: 798] [Article Influence: 29.7] [Reference Citation Analysis]
312 Fey MF. Microsatellite markers in leukaemia and lymphoma: comments on a timely topic. Leuk Lymphoma 1997;28:11-22. [PMID: 9498699 DOI: 10.3109/10428199709058326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
313 Tsuchiya A, Nomizu T, Onda M, Ohki S, Sato H, Abe R. Molecular genetic alteration and DNA ploidy in hereditary nonpolyposis colorectal cancer. Int J Clin Oncol 1997;2:224-9. [DOI: 10.1007/bf02488996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
314 O'Reilly S, Johnson KA, Brensinger JD, Giardiello FM. Hereditary nonpolyposis colorectal cancer. Ann Oncol 1997;8:1151-6. [PMID: 9426336 DOI: 10.1023/a:1008258919849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
315 Loeb LA. Cancer cells exhibit a mutator phenotype. Adv Cancer Res 1998;72:25-56. [PMID: 9338073 DOI: 10.1016/s0065-230x(08)60699-5] [Cited by in Crossref: 140] [Cited by in F6Publishing: 168] [Article Influence: 5.4] [Reference Citation Analysis]
316 Modrich P. Strand-specific mismatch repair in mammalian cells. J Biol Chem 1997;272:24727-30. [PMID: 9312062 DOI: 10.1074/jbc.272.40.24727] [Cited by in Crossref: 181] [Cited by in F6Publishing: 187] [Article Influence: 7.0] [Reference Citation Analysis]
317 Baba S. Hereditary nonpolyposis colorectal cancer: an update. Dis Colon Rectum 1997;40:S86-95. [PMID: 9378019 DOI: 10.1007/BF02062027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
318 Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83. [PMID: 9288102 DOI: 10.1038/ng0997-79] [Cited by in Crossref: 454] [Cited by in F6Publishing: 479] [Article Influence: 17.5] [Reference Citation Analysis]
319 Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-7. [PMID: 9306959 DOI: 10.1002/(SICI)1096-9896(199708)182:4<392::AID-PATH874>3.0.CO;2-G] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
320 Parsons R. Molecular genetics and hereditary cancer. Cancer 1997;80:533-536. [DOI: 10.1002/(sici)1097-0142(19970801)80:3+<533::aid-cncr2>3.0.co;2-a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
321 Grogan L, Kirsch I. Genetic Testing for Cancer Risk Assessment: A Review. The Oncologist 1997;2:208-22. [DOI: 10.1634/theoncologist.2-4-208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
322 Hoops TC, Traber PG. Molecular pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 1997;11:609-33. [PMID: 9257148 DOI: 10.1016/s0889-8588(05)70453-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
323 Voskuil DW, Vasen HF, Kampman E, van't Veer P. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int J Cancer 1997;72:205-9. [PMID: 9219821 DOI: 10.1002/(sici)1097-0215(19970717)72:2<205::aid-ijc1>3.0.co;2-v] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
324 Gelb AB, Schrock TR. Prognostic Factors in Colorectal Carcinoma. Surgical Oncology Clinics of North America 1997;6:463-94. [DOI: 10.1016/s1055-3207(18)30313-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
325 Sekine I, Yokose T, Ogura T, Suzuki K, Nagai K, Kodama T, Mukai K, Nishiwaki Y, Esumi H. Microsatellite instability in lung cancer patients 40 years of age or younger. Jpn J Cancer Res 1997;88:559-63. [PMID: 9263533 DOI: 10.1111/j.1349-7006.1997.tb00419.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
326 Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A, Ponz de Leon M. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer 1997;71:373-6. [PMID: 9139871 DOI: 10.1002/(sici)1097-0215(19970502)71:3<373::aid-ijc12>3.0.co;2-h] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
327 Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7. [PMID: 9121588 DOI: 10.1038/386623a0] [Cited by in Crossref: 1367] [Cited by in F6Publishing: 1458] [Article Influence: 52.6] [Reference Citation Analysis]
328 Vider BZ, Zimber A, Hirsch D, Estlein D, Chastre E, Prevot S, Gespach C, Yaniv A, Gazit A. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997;232:742-8. [PMID: 9126347 DOI: 10.1006/bbrc.1997.6364] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 2.9] [Reference Citation Analysis]
329 Ricote M, Geller P, Perucho M. Frequent alterations in gene expression in colon tumor cells of the microsatellite mutator phenotype. Mutat Res 1997;374:153-67. [PMID: 9100840 DOI: 10.1016/s0027-5107(97)00002-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
330 Lengauer C, Kinzler KW, Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A 1997;94:2545-50. [PMID: 9122232 DOI: 10.1073/pnas.94.6.2545] [Cited by in Crossref: 285] [Cited by in F6Publishing: 296] [Article Influence: 11.0] [Reference Citation Analysis]
331 Codori AM. Psychological opportunities and hazards in predictive genetic testing for cancer risk. Gastroenterol Clin North Am 1997;26:19-39. [PMID: 9119438 DOI: 10.1016/s0889-8553(05)70281-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
332 Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9. [PMID: 9020077 DOI: 10.1126/science.275.5302.967] [Cited by in Crossref: 968] [Cited by in F6Publishing: 1014] [Article Influence: 37.2] [Reference Citation Analysis]
333 Lothe RA. Microsatellite instability in human solid tumors. Mol Med Today 1997;3:61-8. [PMID: 9060003 DOI: 10.1016/S1357-4310(96)10055-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis]
334 Tishkoff DX, Filosi N, Gaida GM, Kolodner RD. A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair. Cell 1997;88:253-63. [PMID: 9008166 DOI: 10.1016/s0092-8674(00)81846-2] [Cited by in Crossref: 347] [Cited by in F6Publishing: 369] [Article Influence: 13.3] [Reference Citation Analysis]
335 Herfarth KK, Kodner IJ, Whelan AJ, Ivanovich JL, Bracamontes JR, Wells SA Jr, Goodfellow PJ. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability. Genes Chromosomes Cancer 1997;18:42-9. [PMID: 8993979 DOI: 10.1002/(sici)1098-2264(199701)18:1<42::aid-gcc5>3.0.co;2-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.3] [Reference Citation Analysis]
336 Green MJ, Fost N. Who Should Provide Genetic Education Prior to Gene Testing? Computers and Other Methods for Improving Patient Understanding. Genetic Testing 1997;1:131-6. [DOI: 10.1089/gte.1997.1.131] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
337 Basik M, Stoler DL, Kontzoglou KC, Rodriguez-bigas MA, Petrelli NJ, Anderson GR. Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysis. Genes Chromosom Cancer 1997;18:19-29. [DOI: 10.1002/(sici)1098-2264(199701)18:1<19::aid-gcc3>3.0.co;2-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.5] [Reference Citation Analysis]
338 Marra G, Boland CR. DNA repair and colorectal cancer. Gastroenterol Clin North Am 1996;25:755-72. [PMID: 8960891 DOI: 10.1016/s0889-8553(05)70273-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
339 Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am 1996;25:793-803. [PMID: 8960893 DOI: 10.1016/s0889-8553(05)70275-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
340 Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70. [PMID: 8861899 DOI: 10.1016/s0092-8674(00)81333-1] [Cited by in Crossref: 3455] [Cited by in F6Publishing: 3603] [Article Influence: 128.0] [Reference Citation Analysis]
341 Fearon ER. DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta 1996;1288:M17-23. [PMID: 8876630 DOI: 10.1016/0304-419x(96)00023-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 0.3] [Reference Citation Analysis]
342 Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations. Nature 1996;382:499-500. [PMID: 8700220 DOI: 10.1038/382499a0] [Cited by in Crossref: 208] [Cited by in F6Publishing: 219] [Article Influence: 7.7] [Reference Citation Analysis]
343 Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996;13:343-6. [PMID: 8673134 DOI: 10.1038/ng0796-343] [Cited by in Crossref: 431] [Cited by in F6Publishing: 463] [Article Influence: 16.0] [Reference Citation Analysis]
344 Rodríguez-Bigas MA, Lee PH, O'Malley L, Weber TK, Suh O, Anderson GR, Petrelli NJ. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:649-53. [PMID: 8646951 DOI: 10.1007/BF02056944] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
345 Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nat Med 1996;2:630-1. [PMID: 8640546 DOI: 10.1038/nm0696-630] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 4.1] [Reference Citation Analysis]
346 Umar A, Kunkel TA. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 1996;238:297-307. [PMID: 8681938 DOI: 10.1111/j.1432-1033.1996.0297z.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 168] [Article Influence: 5.8] [Reference Citation Analysis]
347 Malkhosyan S, McCarty A, Sawai H, Perucho M. Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype. Mutat Res 1996;316:249-59. [PMID: 8649458 DOI: 10.1016/s0921-8734(96)90007-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 2.6] [Reference Citation Analysis]
348 Petersen GM. Genetic counseling and predictive testing for colorectal cancer risk. Int J Cancer 1996;69:53-4. [PMID: 8600062 DOI: 10.1002/(SICI)1097-0215(19960220)69:1<53::AID-IJC13>3.0.CO;2-L] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
349 Boland CR. Roles of the DNA mismatch repair genes in colorectal tumorigenesis. Int J Cancer 1996;69:47-9. [PMID: 8600059 DOI: 10.1002/(SICI)1097-0215(19960220)69:1<47::AID-IJC11>3.0.CO;2-H] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
350 Foulkes WD, Narod SA. Screening for cancer in high-risk families. Cancer Treat Res 1996;86:165-82. [PMID: 8886445 DOI: 10.1007/978-1-4613-1265-9_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
351 Umar A, Kunkel TA. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. EJB Reviews 1996 1996. [DOI: 10.1007/978-3-642-60659-5_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
352 Luce MC, Marra G, Chauhan DP, Laghi L, Carethers JM, Cherian SP, Hawn M, Binnie CG, Kam-Morgan LN, Cayouette MC. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995;109:1368-74. [PMID: 7557107 DOI: 10.1016/0016-5085(95)90600-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 1.4] [Reference Citation Analysis]
353 Welsh J, Rampino N, McClelland M, Perucho M. Nucleic acid fingerprinting by PCR-based methods: applications to problems in aging and mutagenesis. Mutat Res 1995;338:215-29. [PMID: 7565877 DOI: 10.1016/0921-8734(95)00026-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]